24 completed, 10 unknown, 2 recruiting, 2 withdrawn. 12 Not applicable, 9 Phase 2, 9 Phase 3, 6 Phase 4, 2 Phase 1.
Follow Vitreous Hemorrhage: new trials by email Literature Review of Vitreous Hemorrhage trials Research Report on Vitreous Hemorrhage
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study on Eye-Brain Cross-Organ Mapping and Systemic Disease Association Based on Multimodal Big Data No interventions were involved in this study. - Cataract, Vitreous Hemorrhage | Not yet recruiting | Beijing Friendship Hospital | 208000 | 2026-12-25 | 2026-10-16 | |
| Surgical Procedure Efficiency Evaluation stuDy UNITY VCS, CONSTELLATION - Cataract, Vitreous Hemorrhage | Recruiting | Alcon Research | 180 | 2026-02-09 | 2026-08-13 | |
| UNITY VCS Vitreoretinal Surgery UNITY Vitreoretinal Cataract System (VCS), CONSTELLATION Vision System, Vitreoretinal ophthalmic surgery - Epiretinal Membrane, Macular Hole | Not applicable | Withdrawn | Alcon Research | 2026-01-01 | 2025-12-12 | |
| Immediate Postoperative Bevacizumab Administration in Proliferative Diabetic Retinopathy Patients Undergoing Vitrectomy Bevacizumab - Proliferative Diabetic Retinopathy - High Risk | Not applicable | Recruiting | Christian Ophthalmic Surgery Expedition Network | 150 | 2025-03-20 | 2025-03-28 |
| Intraoperative Application of Fluorescein Sodium Angiography in Vascular Retinopathy Intraoperative Fluorescein Angiography - Vascular Retinopathy of Left Eye (Disorder), Vascular Retinopathy of Right Eye (Disorder) | Not applicable | Unknown | Jie Zhong | 80 | 2024-04-18 | 2024-04-03 |
| Comparison of Restoration in Vitreous Hemorrhage Patients With DME After or Not Removing Inner Limiting Membrane Macular Edema Due to Diabetes Mellitus, Vitreous Hemorrhage | Unknown | Second Affiliated Hospital, Zhejiang University, School of Medicine | 120 | 2023-02-10 | 2023-02-06 | |
| Performance Comparison of the 25 Gauge 20,000cpm HYPERVIT Dual Blade vs. 10,000cpm ULTRAVIT Vitrectomy Cutter 25 gauge 20,000 cpm Hypervit Dual Blade, 25 gauge 10,000 cpm Ultravit Vitrectomy Cutter - Vitrectomy, Epiretinal Membrane | Not applicable | Completed | The University of Hong Kong | 72 | 2021-07-01 | 2023-02-02 |
| Clareon Intraocular Lens Stability in Vitrectomy Patients: CLOVE Study Clareon, Tecnis 1 - Senile Cataract, Epiretinal Membrane | Not applicable | Completed | The University of Hong Kong | 50 | 2021-06-07 | 2024-04-25 |
| Pars Plana Vitrectomy With 25-gauge 20000 Cpm, Bevel-tip Cutter 25-gauge, bevel-tip, 20000 cut per minute pars plana vitrectomy - Vitrectomy, Retinal Detachment | Not applicable | Unknown | Peregrine Eye and Laser Institute | 50 | 2021-04-01 | 2021-06-04 |
| Refractive Changes Following Vitrectomy pars plana vitrectomy - Retinal Detachment, Refractive Errors | Completed | Bursa Retina Eye Hospital | 47 | 2020-12-01 | 2021-01-15 | |
| Oral Sedation in Vitreoretinal Surgery Oral Sedatives with or Without Analgesia, Intravenous Sedatives with or Without Analgesia - Macular Holes, Intraocular Lens Opacification | Phase 4 | Unknown | Rocky Vista University, LLC | 80 | 2020-06-01 | 2020-04-15 |
| Performance, Safety and Efficiency Comparison Between 10,000 and 5,000 Cuts Per Minute Vitrectomy Using a 25G Cutter - A Prospective Randomized Controlled Study Alcon 25Gauge, 10,000 cuts per minute Ultravit cutter, Alcon 25Gauge, 5,000 cuts per minute Ultravit cutter - Vitreous Hemorrhage, Macula Hole | Not applicable | Completed | The University of Hong Kong | 52 | 2018-05-01 | 2021-04-26 |
| IVB for Post-vitrectomy Hemorrhage in Diabetic Eyes Bevacizumab Injection [Avastin], Pars Plana Vitrectomy - Diabetic Retinopathy, Vitreous Hemorrhage | Not applicable | Completed | Universitas Padjadjaran | 18 | 2018-04-02 | 2024-08-27 |
| Cryoapplication Versus Anti-VEGF Before Diabetic Vitrectomy Bevacizumab Injection [Avastin], Peripheral Retinal Cryoapplication - Proliferative Diabetic Retinopathy, Vitreous Hemorrhage | Phase 4 | Unknown | Khairallah Moncef | 60 | 2017-11-21 | 2022-08-31 |
| Combined Vitrectomy and Femtosecond Laser-assisted Cataract Surgery FLACS +PPV+IOL + air, FLACS +PPV+IOL + epiretinal membrane peeling + Ozurdex, FLACS + PPV+IOL + internal limiting membrane peeling + air - Macular Disease, Rhegmatogenous Retinal Detachment | Not applicable | Unknown | Aier School of Ophthalmology, Central South University | 100 | 2017-01-01 | 2022-10-20 |
| Anti-VEGF vs. Prompt Vitrectomy for VH From PDR 2-mg Intravitreous Aflibercept Injection, Prompt Vitrectomy Plus Panretinal Photocoagulation - Proliferative Diabetic Retinopathy, Vitreous Hemorrhage | Phase 2 / Phase 3 | Completed | Jaeb Center for Health Research | 205 | 2016-11-01 | 2021-04-20 |
| Endolaserless Vitrectomy With Intravitreal IAI for PDR-Related VH Aflibercept, Endolaserless Vitrectomy - Proliferative Diabetic Retinopathy | Phase 1 / Phase 2 | Unknown | Southeast Retina Center, Georgia | 24 | 2016-06-01 | 2016-11-29 |
| Use of Intravitreal Ranibizumab in the Treatment of Vitreous Hemorrhage intravitreal ranibizumab injections - Diabetic Retinopathy, Vitreous Hemorrhage | Phase 4 | Unknown | Hospital Regional de São José - Dr. Homero de Miranda Gomes | 20 | 2013-03-01 | 2013-04-04 |
| Aflibercept Injection for Proliferative Diabetic Retinopathy Intravitreal Aflibercept Injection, Standard Vitrectomy - Vitreous Hemorrhage | Phase 2 | Completed | University of Oklahoma | 12 | 2013-03-01 | 2023-12-27 |
| Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy intravitreal injection of bevacizumab - Vitreous Hemorrhage, Proliferative Diabetic Retinopathy | Phase 4 | Completed | Khon Kaen University | 18 | 2012-08-01 | 2013-04-26 |
Showing 20 of 39. Sign in to see all of them.
Diabetic Retinopathy (12) · Retinal Detachment (10) · Epiretinal Membrane (9) · Retinal Perforations (6) · Cataract (4) · Diabetes Mellitus (2) · Macular Degeneration (2) · Cerebral Small Vessel Diseases (1) · Hemorrhage (1) · Keratitis (1) · Macular Edema (1) · Neovascularization, Pathologic (1) · Postoperative Complications (1) · Pterygium (1)
Eye Diseases (39) · Eye Hemorrhage (39) · Pathologic Processes (39) · Pathological Conditions, Signs and Symptoms (39) · Hemorrhage (38) · Retinal Diseases (23) · Cardiovascular Diseases (13) · Endocrine System Diseases (13) · Vascular Diseases (13) · Diabetes Complications (12) · Diabetic Angiopathies (12) · Diabetes Mellitus (11) · Lens Diseases (4) · Retinal Degeneration (3) · Glucose Metabolism Disorders (2)
Bevacizumab (11) · Vitrectomy (3) · aflibercept (3) · Calcium Dobesilate (2) · Chondroitinases and Chondroitin Lyases (2) · Ranibizumab (2) · salicylhydroxamic acid (2) · Air (1) · Analgesia (1) · Dexamethasone (1) · Hyaluronoglucosaminidase (1) · Hypnotics and Sedatives (1) · Intravitreal Injections (1) · Propofol (1) · Remifentanil (1)
University of Sao Paulo (4) · National Taiwan University Hospital (3) · The University of Hong Kong (3) · Alcon Research (2) · Bausch & Lomb Incorporated (2) · Jaeb Center for Health Research (2) · National Eye Institute (NEI) (2) · Seoul National University Bundang Hospital (2) · Aier School of Ophthalmology, Central South University (1) · Anders Kvanta (1) · Beijing Friendship Hospital (1) · Bursa Retina Eye Hospital (1) · Christian Ophthalmic Surgery Expedition Network (1) · Greater Houston Retina Research (1) · Hospital Regional de São José - Dr. Homero de Miranda Gomes (1)
United States (7) · Brazil (6) · Hong Kong (3) · Taiwan (3) · Canada (2) · China (2) · Mexico (2) · South Korea (2) · United Kingdom (2) · Australia (1) · Austria (1) · Hungary (1) · Indonesia (1) · Iran (1) · Italy (1)
Chung-May Yang, MD (3) · Lisa R Grillone, PhD (2) · Abdhish Bhavsar, MD (1) · Adam R. Glassman, MS (1) · Anders Kvanta, PhD (1) · Andrew Antoszyk, MD (1) · Ayumu Manabe (1) · Barbara Wimpissinger, MD (1) · Daniel R Lucena, MD (1) · Dennis M Marcus, MD (1) · Felipe Almeida, MD (1) · Hamid Ahmadieh, MD (1) · Harvey S Uy, MD (1)
PMID 37260074, PMID 18441312, PMID 18851731, PMID 19208678, PMID 23370902, PMID 28860046, PMID 30705040, PMID 31047488, PMID 33320223, PMID 33956075, PMID 37972038
U10EY014231 (1), U10EY018817 (1)